GLUE icon

Monte Rosa Therapeutics

68 hedge funds and large institutions have $272M invested in Monte Rosa Therapeutics in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 33 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

12% less capital invested

Capital invested by funds: $310M → $272M (-$37.5M)

Holders
68
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$511K
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$22.5M
2 -$11.7M
3 -$912K
4
TD Asset Management
TD Asset Management
Ontario, Canada
-$166K
5
Squarepoint
Squarepoint
New York
-$109K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$560K
27
$446K
28
$368K
29
$350K
30
$322K
31
$311K
32
$308K
33
$255K
34
$236K
35
$213K
36
$193K
37
$193K
38
$174K
39
$163K
40
$163K
41
$150K
42
$147K
43
$144K
44
$136K
45
$124K
46
$101K
47
$101K
48
$101K
49
$99.2K
50
$95.6K